InsiderPulse| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-19 | 2026-03-20 | DOUGLAS RICHARD | Director | Purchase | 70.0K | $1.40 | $98K | 195.0K | View ↗ | |
| 2026-03-18 | 2026-03-19 | Alfieri Michael | Principal Financial Officer | Purchase | 5,000 | $1.42 | $7K | 7,500 | View ↗ |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Research and development | $25.7M-46.8% | $48.2M+63.7% | $29.5M-37.7% | $47.3M |
| General and administrative | $9.6M-19.3% | $11.9M-10.8% | $13.3M-13.3% | $15.4M |
| Loss from operations | -$35.3M+41.3% | -$60.1M-40.5% | -$42.8M+31.7% | -$62.7M |
| Interest income | $3.3M-46.3% | $6.2M-15.4% | $7.3M+211.7% | $2.3M |
| Interest expense | -$1.9M+1.1% | -$1.9M+7.0% | -$2.1M-22.3% | -$1.7M |
| Total other income, net | $1.4M-66.7% | $4.3M-18.8% | $5.3M+701.3% | $655K |
| Net loss | -$33.8M+39.4% | -$55.9M-48.8% | -$37.5M+39.5% | -$62.0M |
| Net loss per share - basic | -$0.56+40.4% | -$0.94-46.9% | -$0.64+39.6% | -$1.06 |
| Net loss per share - diluted | -$0.56+40.4% | -$0.94-46.9% | -$0.64+39.6% | -$1.06 |
| Weighted average common shares outstanding - basic | $60.1M+1.0% | $59.5M+0.9% | $58.9M+0.9% | $58.4M |
| Weighted average common shares outstanding - diluted | $60.1M+1.0% | $59.5M+0.9% | $58.9M+0.9% | $58.4M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Pleasing Signs As A Number Of Insiders Buy Aldeyra Therapeutics Stock
Extreme Networks And 2 Additional Stocks Estimated To Be Trading Below Their Fair Value
Discover 3 Stocks That Might Be Trading Below Estimated Value
3 Stocks Estimated To Be Trading Below Intrinsic Value By Up To 35.4%